Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.
about
Clinical use of whole genome sequencing for Mycobacterium tuberculosisRisk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-AnalysisThe impact of isoniazid resistance on the treatment outcomes of smear positive re-treatment tuberculosis patients in the state of Andhra Pradesh, IndiaComparative evaluation of GenoType MTBDRplus line probe assay with solid culture method in early diagnosis of multidrug resistant tuberculosis (MDR-TB) at a tertiary care centre in IndiaHas introduction of rapid drug susceptibility testing at diagnosis impacted treatment outcomes among previously treated tuberculosis patients in Gujarat, India?High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosisPrevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin-Mono-Resistant Pulmonary Tuberculosis in Lima, PeruCost-Effectiveness of Community-Based TB/HIV Screening and Linkage to Care in Rural South AfricaMycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance.Isoniazid-resistant tuberculosis: a cause for concern?Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisHigh isoniazid resistance rates in rifampicin susceptible Mycobacterium tuberculosis pulmonary isolates from Pakistan.First insights into circulating Mycobacterium tuberculosis complex lineages and drug resistance in Guinea.Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary TuberculosisEffect of mycobacterial drug resistance patterns on patients' survival: a cohort study in Thailand.First Evaluation of GenoType MTBDRplus 2.0 Performed Directly on Respiratory Specimens in Central AmericaRifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis.Evaluation of two line probe assays for rapid detection of Mycobacterium tuberculosis, tuberculosis (TB) drug resistance, and non-TB Mycobacteria in HIV-infected individuals with suspected TB.Rapid detection of isoniazid resistance in Mycobacterium tuberculosis isolates by use of real-time-PCR-based melting curve analysis.Drug-resistant tuberculous meningitis.Novel diagnostics and therapeutics for drug-resistant tuberculosis.Isoniazid-resistant tuberculosis in Birmingham, United Kingdom, 1999-2010.Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis.Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis.Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.The disconnect between a national tuberculosis drug resistance survey and treatment outcomes: a lost opportunity.Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada.Do we need to detect isoniazid resistance in addition to rifampicin resistance in diagnostic tests for tuberculosis?Investigation of Ser315 substitutions within katG gene in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from south India.7th Union Europe Conference on Lung Health, 22-24 June 2016, Bratislava (Slovakia): a delegate report.Impact of alcohol consumption on tuberculosis treatment outcomes: a prospective longitudinal cohort study protocol
P2860
Q26752636-B8CC35C9-0034-48C9-A4E4-478A4AC95E6FQ26781111-BE35E2FB-3A60-4035-9F9A-2F64EEC8ED92Q28534364-D3F48EEB-5249-4C90-9513-E5262656B557Q28536857-D1135C56-C500-4970-9997-A0561C251AA9Q28546196-9E354823-5D92-42A9-9174-C41172D89FBAQ28546682-7754FFD9-A855-467D-84E3-9C97AB3EB3DAQ28551162-E0ABC854-ADCE-4583-BACD-6AFEC8CA01F7Q28554655-7E4D1390-A26C-4BD0-B885-9941CF516C6BQ30385967-E2506586-5D78-4722-AE97-FF0232B16A74Q33820505-332AB2F1-9C3D-423E-8C1C-946C20721E0FQ33926262-332DAF47-0389-417C-98F6-8660DC2DD8BBQ34505509-7596FBF6-6402-4562-8AD5-D26F29E7C972Q35856542-564E21A7-5DD6-4F23-8CD3-1C7DC0E01E55Q35909558-F24C16DD-FEBE-47CA-8232-DE6CBACEE291Q35914813-64BC6501-156E-444D-95B3-D73D3C6BA6E2Q36439006-DCAF7788-1D67-42BD-A9E5-3284590768D1Q36647836-B8C3F2E7-7A65-4375-8F6C-A03D75CC6E35Q37280660-78DE702D-1C2F-44AD-84F8-6DBB11203FFCQ37502309-FF0F1978-6F0A-4358-B478-98A80A47C0BEQ37713474-1CE43F48-14C8-4329-B6DD-A8F6B9CB6C41Q37713663-11E84445-E634-449B-8277-5E96EAA79722Q38113260-DD55EC10-35C4-4F28-94DB-57F627AD52A9Q38210363-AD2833CB-FCDD-4EB4-8D6D-0E5F056761DFQ38225730-6C8FF116-ACF2-43BB-A254-45A8E1C6F12BQ38839490-7448427E-0059-4D69-A085-C1FFE06358A6Q38950600-686373A0-4E46-4922-9001-0105A8DC3134Q39094119-9A60E768-565C-4914-A3A9-F335160E9B91Q40210228-75E6E6AC-1C5D-416F-822C-FF31A038B939Q40794783-69696D45-F228-4E8C-9839-6608F3CBC0AEQ41611075-3E204321-4636-44E9-B869-B3192DE6121AQ41849725-1028EF60-4963-49C1-B0C3-39D4DC075F49Q42180778-4694CB0F-B67E-4482-8CF1-BDCB43B6A69FQ42398699-83A7F264-2F4D-4548-9B7C-C6EB588EE9D7Q57146848-3A6ED9CF-E25D-4453-81C4-242D9801A223
P2860
Treatment outcomes of isoniazid-resistant tuberculosis patients, Western Cape Province, South Africa.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@ast
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@en
type
label
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@ast
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@en
prefLabel
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@ast
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@en
P2093
P2860
P50
P356
P1476
Treatment outcomes of isoniazi ...... n Cape Province, South Africa.
@en
P2093
Danie Theron
Megan B Murray
Thomas C Victor
P2860
P304
P356
10.1093/CID/CIR406
P407
P577
2011-08-01T00:00:00Z